Press "Enter" to skip to content

Regeneron, Bayer Offer More Promising Data for Aging Eye Drug

https://www.bloomberg.com/news/articles/2022-11-05/regeneron-bayer-offer-more-promising-data-for-aging-eye-drug
Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »